128 related articles for article (PubMed ID: 19066582)
1. Molecular evolution of the tre recombinase.
Buchholz F
J Vis Exp; 2008 May; (15):. PubMed ID: 19066582
[TBL] [Abstract][Full Text] [Related]
2. Interview: HIV-1 proviral DNA excision using an evolved recombinase.
Hauber J
J Vis Exp; 2008 Jun; (16):. PubMed ID: 19066545
[TBL] [Abstract][Full Text] [Related]
3. Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase.
Mariyanna L; Priyadarshini P; Hofmann-Sieber H; Krepstakies M; Walz N; Grundhoff A; Buchholz F; Hildt E; Hauber J
PLoS One; 2012; 7(2):e31576. PubMed ID: 22348110
[TBL] [Abstract][Full Text] [Related]
4. SeLOX--a locus of recombination site search tool for the detection and directed evolution of site-specific recombination systems.
Surendranath V; Chusainow J; Hauber J; Buchholz F; Habermann BH
Nucleic Acids Res; 2010 Jul; 38(Web Server issue):W293-8. PubMed ID: 20529878
[TBL] [Abstract][Full Text] [Related]
5. In vitro evolution and analysis of HIV-1 LTR-specific recombinases.
Buchholz F; Hauber J
Methods; 2011 Jan; 53(1):102-9. PubMed ID: 20600935
[TBL] [Abstract][Full Text] [Related]
6. A novel mutant loxP containing part of long terminal repeat of HIV-1 in spacer region: presentation of possible target site for antiviral strategy using site-specific recombinase.
Lee Y; Park J
Biochem Biophys Res Commun; 1998 Dec; 253(3):588-93. PubMed ID: 9918772
[TBL] [Abstract][Full Text] [Related]
7. Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.
Karpinski J; Hauber I; Chemnitz J; Schäfer C; Paszkowski-Rogacz M; Chakraborty D; Beschorner N; Hofmann-Sieber H; Lange UC; Grundhoff A; Hackmann K; Schrock E; Abi-Ghanem J; Pisabarro MT; Surendranath V; Schambach A; Lindner C; van Lunzen J; Hauber J; Buchholz F
Nat Biotechnol; 2016 Apr; 34(4):401-9. PubMed ID: 26900663
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 proviral DNA excision using an evolved recombinase.
Sarkar I; Hauber I; Hauber J; Buchholz F
Science; 2007 Jun; 316(5833):1912-5. PubMed ID: 17600219
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA.
Meinke G; Karpinski J; Buchholz F; Bohm A
Nucleic Acids Res; 2017 Sep; 45(16):9726-9740. PubMed ID: 28934476
[TBL] [Abstract][Full Text] [Related]
10. Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolates.
Karpinski J; Chemnitz J; Hauber I; Abi-Ghanem J; Paszkowski-Rogacz M; Surendranath V; Chakrabort D; Hackmann K; Schröck E; Pisabarro MT; Hauber J; Buchholz F
J Int AIDS Soc; 2014; 17(4 Suppl 3):19706. PubMed ID: 25397454
[TBL] [Abstract][Full Text] [Related]
11. Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice.
Hauber I; Hofmann-Sieber H; Chemnitz J; Dubrau D; Chusainow J; Stucka R; Hartjen P; Schambach A; Ziegler P; Hackmann K; Schröck E; Schumacher U; Lindner C; Grundhoff A; Baum C; Manz MG; Buchholz F; Hauber J
PLoS Pathog; 2013; 9(9):e1003587. PubMed ID: 24086129
[TBL] [Abstract][Full Text] [Related]
12. An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits Cre recombinase-mediated DNA excision.
Lee YS; Kim ST; Kim GW; Lee M; Park JS
Biochem Cell Biol; 2000; 78(6):653-8. PubMed ID: 11206575
[TBL] [Abstract][Full Text] [Related]
13. Directed evolution of recombinase specificity by split gene reassembly.
Gersbach CA; Gaj T; Gordley RM; Barbas CF
Nucleic Acids Res; 2010 Jul; 38(12):4198-206. PubMed ID: 20194120
[TBL] [Abstract][Full Text] [Related]
14. Prediction of designer-recombinases for DNA editing with generative deep learning.
Schmitt LT; Paszkowski-Rogacz M; Jug F; Buchholz F
Nat Commun; 2022 Dec; 13(1):7966. PubMed ID: 36575171
[TBL] [Abstract][Full Text] [Related]
15. Engineering of a target site-specific recombinase by a combined evolution- and structure-guided approach.
Abi-Ghanem J; Chusainow J; Karimova M; Spiegel C; Hofmann-Sieber H; Hauber J; Buchholz F; Pisabarro MT
Nucleic Acids Res; 2013 Feb; 41(4):2394-403. PubMed ID: 23275541
[TBL] [Abstract][Full Text] [Related]
16. Directed evolution of the site specificity of Cre recombinase.
Santoro SW; Schultz PG
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4185-90. PubMed ID: 11904359
[TBL] [Abstract][Full Text] [Related]
17. Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1.
Beschorner N; Künzle P; Voges M; Hauber I; Indenbirken D; Nakel J; Virdi S; Bradtke P; Lory NC; Rothe M; Paszkowski-Rogacz M; Buchholz F; Grundhoff A; Schambach A; Thirion C; Mittrücker HW; Schulze Zur Wiesch J; Hauber J; Chemnitz J
PLoS One; 2024; 19(3):e0298542. PubMed ID: 38457474
[TBL] [Abstract][Full Text] [Related]
18. Alteration of Cre recombinase site specificity by substrate-linked protein evolution.
Buchholz F; Stewart AF
Nat Biotechnol; 2001 Nov; 19(11):1047-52. PubMed ID: 11689850
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
20. Evolution of programmable zinc finger-recombinases with activity in human cells.
Gordley RM; Smith JD; Gräslund T; Barbas CF
J Mol Biol; 2007 Mar; 367(3):802-13. PubMed ID: 17289078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
